What to expect from a third step in treatment resistant depression: A prospective open study on escitalopram-Reference-Cited by-同舟云学术

What to expect from a third step in treatment resistant depression: A prospective open study on escitalopram

Published:2014-12-23 Issue:7 Volume:16 Page:472-482
ISSN:1562-2975
Container-title:The World Journal of Biological Psychiatry
language:en
Short-container-title:The World Journal of Biological Psychiatry

Author:

Souery Daniel,Calati Raffaella,Papageorgiou Konstantinos,Juven-Wetzler Alzbeta,Gailledreau Joël,Modavi David,Sentissi Othman,Pitchot William,Papadimitriou George N.,Dikeos Dimitris,Montgomery Stuart,Kasper Siegfried,Zohar Joseph,Serretti Alessandro,Mendlewicz Julien

Publisher

Informa UK Limited

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

http://www.tandfonline.com/doi/pdf/10.3109/15622975.2014.987814

Reference50 articles.

1. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression

2. A Double-Blind Comparison of Escitalopram and Venlafaxine Extended Release in the Treatment of Major Depressive Disorder

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmakotherapie: Therapieresistenz;Praxishandbuch Depression;2023

2. Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: A nationwide cohort study;Journal of Affective Disorders;2022-07

3. Involvement of dopamine D2 and glutamate NMDA receptors in the antidepressant-like effect of amantadine in mice;Behavioural Brain Research;2021-09

4. Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression;Journal of Affective Disorders;2021-01

5. Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samples;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2020-04